File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Collaborative multidisciplinary management and expertise of cT2–3 locally advanced operable esophageal squamous cell carcinoma: a report of two cases

TitleCollaborative multidisciplinary management and expertise of cT2–3 locally advanced operable esophageal squamous cell carcinoma: a report of two cases
Authors
Keywordscase report
Clinical staging
esophageal cancer
multidisciplinary treatment
Issue Date21-Nov-2023
PublisherAME Publishing
Citation
Journal of Thoracic Disease, 2023, v. 15, n. 11, p. 6362-6372 How to Cite?
Abstract

Background: The accurate clinical staging of esophageal squamous cell carcinoma (ESCC) is pivotal for guiding treatment strategies. However, the current precision in staging for clinical T (cT)2 and cT3 stages remains unsatisfactory. This article discusses the role of multidisciplinary teams (MDTs) in the clinical staging and formulation of neoadjuvant treatment strategies for locally advanced operable ESCC. These challenges underscore the importance of precise staging in the decision-making process for appropriate therapeutic interventions.

Case Description: Through the lens of two patient case studies with locally advanced resectable ESCC, the article showcases the intricate process of treatment planning undertaken by MDTs. It captures a range of expert perspectives from Japan, China, Hong Kong (China), Korea, the USA, and Europe, focusing on the challenges of differentiating between cT2 and cT3 stages of the disease, which is a critical determinant in the management and therapeutic approach for patients.

Conclusions: The article concludes that the accurate staging of ESCC is a cornerstone in determining the most suitable treatment strategies. It underscores the vital role that MDTs play in both clinical staging and the decision-making process for treatment. Highlighting the limitations in current diagnostic methods, the article emphasizes the urgent need for advanced research and the refinement of diagnostic tools to improve the precision of staging, particularly between the cT2 and cT3 stages. It suggests that future research should consider whether a reclassification of these stages could be warranted to enhance treatment planning and outcomes for patients with ESCC.


Persistent Identifierhttp://hdl.handle.net/10722/340612
ISSN
2023 Impact Factor: 2.1
2023 SCImago Journal Rankings: 0.651
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLeng, Xuefeng-
dc.contributor.authorKurita, Daisuke-
dc.contributor.authorZhu, Yi-
dc.contributor.authorAbe, Seiichiro-
dc.contributor.authorZhang, Ruixiang-
dc.contributor.authorGuo, Xufeng-
dc.contributor.authorDai, Liang-
dc.contributor.authorWong, Ian Yu-Hong-
dc.contributor.authorPark, Seong Yong-
dc.contributor.authorWilk, Berend J van der-
dc.contributor.authorGao, Xing-
dc.contributor.authorChen, Yung-Chang-
dc.contributor.authorZhao, Rui-
dc.contributor.authorLv, Jiahua-
dc.contributor.authorQing, Haomiao-
dc.contributor.authorLiu, Yang-
dc.contributor.authorMitchell, Kyle G-
dc.contributor.authorWijnhoven, Bas P L-
dc.contributor.authorHan, Yongtao-
dc.contributor.authorDaiko, Hiroyuki-
dc.date.accessioned2024-03-11T10:45:53Z-
dc.date.available2024-03-11T10:45:53Z-
dc.date.issued2023-11-21-
dc.identifier.citationJournal of Thoracic Disease, 2023, v. 15, n. 11, p. 6362-6372-
dc.identifier.issn2072-1439-
dc.identifier.urihttp://hdl.handle.net/10722/340612-
dc.description.abstract<p><strong>Background: </strong>The accurate clinical staging of esophageal squamous cell carcinoma (ESCC) is pivotal for guiding treatment strategies. However, the current precision in staging for clinical T (cT)2 and cT3 stages remains unsatisfactory. This article discusses the role of multidisciplinary teams (MDTs) in the clinical staging and formulation of neoadjuvant treatment strategies for locally advanced operable ESCC. These challenges underscore the importance of precise staging in the decision-making process for appropriate therapeutic interventions.</p><p><strong>Case Description: </strong>Through the lens of two patient case studies with locally advanced resectable ESCC, the article showcases the intricate process of treatment planning undertaken by MDTs. It captures a range of expert perspectives from Japan, China, Hong Kong (China), Korea, the USA, and Europe, focusing on the challenges of differentiating between cT2 and cT3 stages of the disease, which is a critical determinant in the management and therapeutic approach for patients.</p><p><strong>Conclusions: </strong>The article concludes that the accurate staging of ESCC is a cornerstone in determining the most suitable treatment strategies. It underscores the vital role that MDTs play in both clinical staging and the decision-making process for treatment. Highlighting the limitations in current diagnostic methods, the article emphasizes the urgent need for advanced research and the refinement of diagnostic tools to improve the precision of staging, particularly between the cT2 and cT3 stages. It suggests that future research should consider whether a reclassification of these stages could be warranted to enhance treatment planning and outcomes for patients with ESCC.</p>-
dc.languageeng-
dc.publisherAME Publishing-
dc.relation.ispartofJournal of Thoracic Disease-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectcase report-
dc.subjectClinical staging-
dc.subjectesophageal cancer-
dc.subjectmultidisciplinary treatment-
dc.titleCollaborative multidisciplinary management and expertise of cT2–3 locally advanced operable esophageal squamous cell carcinoma: a report of two cases-
dc.typeArticle-
dc.identifier.doi10.21037/jtd-23-1277-
dc.identifier.scopuseid_2-s2.0-85178482373-
dc.identifier.volume15-
dc.identifier.issue11-
dc.identifier.spage6362-
dc.identifier.epage6372-
dc.identifier.eissn2077-6624-
dc.identifier.isiWOS:001109118200001-
dc.identifier.issnl2072-1439-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats